CTI BIOPHARMA CORP's ticker is CTICXXXX and the CUSIP is 12648L106. A total of 97 filers reported holding CTI BIOPHARMA CORP in Q1 2015. The put-call ratio across all filers is 0.31 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $464,000 | -9.9% | 1,137,955 | -17.3% | 0.00% | – |
Q3 2016 | $515,000 | +1.6% | 1,375,394 | -7.7% | 0.00% | – |
Q2 2016 | $507,000 | +692.2% | 1,490,528 | +1137.2% | 0.00% | – |
Q1 2016 | $64,000 | -83.9% | 120,480 | -62.8% | 0.00% | – |
Q4 2015 | $398,000 | +0.5% | 323,509 | +19.1% | 0.00% | – |
Q3 2015 | $396,000 | -59.6% | 271,582 | -45.9% | 0.00% | – |
Q2 2015 | $979,000 | +53.4% | 502,188 | +42.4% | 0.00% | – |
Q1 2015 | $638,000 | -54.0% | 352,700 | -39.9% | 0.00% | – |
Q4 2014 | $1,386,000 | +26.6% | 587,078 | +29.7% | 0.00% | – |
Q3 2014 | $1,095,000 | -3.1% | 452,470 | +12.5% | 0.00% | – |
Q2 2014 | $1,130,000 | – | 402,051 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
EAGLE ASSET MANAGEMENT INC | 15,707,022 | $38,010,000 | 0.11% |
First Heartland Consultants, Inc. | 74,624 | $181,000 | 0.08% |
WASHINGTON TRUST Co | 410,616 | $994,000 | 0.07% |
Geduld E E | 40,000 | $97,000 | 0.07% |
FIRST NEW YORK SECURITIES LLC /NY | 30,562 | $73,960,000 | 0.05% |
Crosspoint Capital Strategies, LLC | 25,000 | $61,000 | 0.04% |
JANE STREET GROUP, LLC | 1,434,975 | $3,473,000 | 0.04% |
MAGEE THOMSON INVESTMENT PARTNERS LLC | 21,479 | $51,000 | 0.01% |
TIAA CREF TRUST CO FSB/MO | 296,322 | $717,000 | 0.01% |
Investors Capital Advisory Services | 16,950 | $41,000 | 0.01% |